The description of quantitative structure¿activity relationship (QSAR) models has been a topic for scientific research for more than 40 years and a topic within the regulatory framework for more than 20 years. At present, efforts on QSAR development are increasing because of their promise for supporting reduction, refinement, and/or replacement of animal toxicity experiments. However, their acceptance in risk assessment seems to require a more standardized and scientific underpinning of QSAR technology to avoid possible pitfalls. For this reason, guidelines for QSAR model development recently proposed by the Organization for Economic Cooperation and Development (OECD) [ Organization for Economic Cooperation and Development (OECD) (2007) Gui...
Little or nothing is known about the toxicity of most of the >100,000 chemicals released into the en...
Quantitative structure-activity relationship (QSAR) models are widely used for in silico prediction ...
Together oral bioavailability and hepatotoxicity determine the fate and failure of a new drug in cli...
The description of quantitative structure¿activity relationship (QSAR) models has been a topic for s...
Improving regulatory confidence in, and acceptance of, a prediction of toxicity from a quantitative ...
Improving regulatory confidence in, and acceptance of, a prediction of toxicity from a quantitative ...
Structure Activity Relationships are computational techniques used to predict biological activities ...
The conditions and methods for constructing reliable QSARs are revised in relation to each component...
This paper reviews Quantitative Structure-Activity Relationship (QSAR) models for acute mammalian to...
This paper reviews Quantitative Structure-Activity Relationship (QSAR) models for acute mammalian to...
In silico models are used to predict toxicity and molecular properties in chemical safety assessment...
In this project quantitative structure-activity relationships (QSARs) were developed for several tox...
This article is a review of the use of quantitative (and qualitative) structure-activity relationshi...
Untested chemicals released into the market could have harmful effects on human health and the envir...
Untested chemicals released into the market could have harmful effects on human health and the envir...
Little or nothing is known about the toxicity of most of the >100,000 chemicals released into the en...
Quantitative structure-activity relationship (QSAR) models are widely used for in silico prediction ...
Together oral bioavailability and hepatotoxicity determine the fate and failure of a new drug in cli...
The description of quantitative structure¿activity relationship (QSAR) models has been a topic for s...
Improving regulatory confidence in, and acceptance of, a prediction of toxicity from a quantitative ...
Improving regulatory confidence in, and acceptance of, a prediction of toxicity from a quantitative ...
Structure Activity Relationships are computational techniques used to predict biological activities ...
The conditions and methods for constructing reliable QSARs are revised in relation to each component...
This paper reviews Quantitative Structure-Activity Relationship (QSAR) models for acute mammalian to...
This paper reviews Quantitative Structure-Activity Relationship (QSAR) models for acute mammalian to...
In silico models are used to predict toxicity and molecular properties in chemical safety assessment...
In this project quantitative structure-activity relationships (QSARs) were developed for several tox...
This article is a review of the use of quantitative (and qualitative) structure-activity relationshi...
Untested chemicals released into the market could have harmful effects on human health and the envir...
Untested chemicals released into the market could have harmful effects on human health and the envir...
Little or nothing is known about the toxicity of most of the >100,000 chemicals released into the en...
Quantitative structure-activity relationship (QSAR) models are widely used for in silico prediction ...
Together oral bioavailability and hepatotoxicity determine the fate and failure of a new drug in cli...